Dynamics of NITs (LIVERFASt, FIB-4, VCTE) during monitoring therapy with Resmetirom in patients with MASH — update
Dynamics of NITs (LIVERFASt, FIB-4, VCTE) during monitoring therapy with Resmetirom in patients with MASH — update
Correlations between LIVERFASt, MRE for fibrosis assessment and ICFF for steatosis assessment in MASLD patients
Correlations between LIVERFASt, MRE for fibrosis assessment and ICFF for steatosis assessment in MASLD patients
Application of LIVERFASt to predict steatosis in Chronic Hepatitis B patients with metabolic syndrome
Application of LIVERFASt to predict steatosis in Chronic Hepatitis B patients with metabolic syndrome